Jab1 Interacts Directly with HIF-1α and Regulates Its Stability
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Hypoxia-inducible factor-1 (HIF-1) is a master transcription factor that controls transcriptional activation of a number of genes responsive to the low cellular oxygen tension, including vascular endothelial growth factor (VEGF), erythropoietin, and glycolytic enzymes. The stability and activity of HIF-1alpha are regulated by binding to various proteins such as pVHL, p53, and p300/CBP. Here, using the yeast two-hybrid screening system, we found that HIF-1alpha interacts with Jab1 (Jun activation domain-binding protein-1), which is a coactivator of AP-1 transcription factor and fifth subunit of COP9 signalosome complex. The interaction of Jab1 with HIF-1alpha was confirmed by GST pull-down assay and also reproduced in vivo in HEK 293 cells, where endogenous Jab1 was coimmunoprecipitated with the overexpressed HIF-1alpha. Moreover, Jab1-enhanced transcriptional activity of HIF-1 under hypoxia led to increase the expression of VEGF, a major HIF-1 target gene. Furthermore, Jab1 increased HIF-1alpha protein levels, which was due to the enhanced HIF-1alpha stability. The binding of HIF-1alpha and p53 tumor suppressor protein, negative regulator of HIF-1alpha stability, was interfered in a Jab1-dependent manner. Taken together, these results indicate that Jab1 should be considered as a novel regulator of HIF-1alpha stability via direct interaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![FIG. 3 Jab1 increases HIF-1 𝛂 stability in response to hypoxia. A , HEK 293 cells were transfected with indicated expression vector and left untreated or exposed to 1% O 2 for 5 h. HIF-1 𝛂 protein levels by Western blot from protein extracts were examined ( top two panels ). Reverse transcriptase-PCR analysis ( bottom two panels ) was performed using specific primer for HIF-1 𝛂 and 𝛃 -actin. Lanes 1 and 3 , empty vector-transfected cells; lanes 2 and 4 , Jab1-transfected cells. B , the empty vector-transfected cells and Jab1-transfected cells were exposed for 5 h to 1% O 2 and followed by the addition of 100 𝛍 M cycloheximide ( CHX ) for 30 min in 1% O 2 . Cell lysates were harvested and subjected to immunoblot analysis of HIF-1 𝛂 . C , HEK 293 cells transfected with pBOS-HIF-1 𝛂 and pCMV-Jab1 ( open circles ) or pCMV alone ( closed circles ) were pulsed with [ 35 S]methionine and then chased for 0.5, 1, and 2 h under hypoxia. Cell lysates were immunoprecipitated with anti-HIF-1 𝛂 antibody. The intensity of HIF-1 𝛂 signals was quantified and plotted.](https://figures.cochat.ai/paper-figures/ae9eea1b6c574695bb9ba85cc2d6d293/jab1-interacts-directly-with-hif-1-and-regulates-its-stability-figure-3.png)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It was observed that loss of p53 tumor suppressor gene in certain types of tumors is associated with elevated levels of HIF-1α40.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [40]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
Ravi, R. K., Mookerjee, B., Bhujwalla, Z. M., Sutter, T. R., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · PubMed Central · Cited by 1,230
Oxygen sensing and molecular adaptation to hypoxia
Bunn, H. F., & Poyton, R. O. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.3.839 · Cited by 1,172
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · Genes & Development · doi:10.1101/gad.14.1.34 · Cited by 967
Tanimoto, K., Makino, Y., Pereira, T., & Poellinger, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4298 · Cited by 928
Stabilization of wild-type p53 by hypoxia-inducible factor 1α
An, W. G., Kanekal, M., Simon, M. C., Maltepe, E., Blagosklonny, M. V., & Neckers, L. M. (1998) · Nature · doi:10.1038/32925 · Cited by 827
An essential role for p300/CBP in the cellular response to hypoxia
Arany, Z., Huang, L. E., Eckner, R., Bhattacharya, S., Jiang, C., Goldberg, M. A., Bunn, H. F., & Livingston, D. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12969 · Cited by 790
Research works printed but not linked: 1
- 9. Arany, Z., Huang, L. E., Eckner, R., Bhattacharya, S., Jiang, C., Goldberg, M. A., Bunn, H. F., and Livingston, D. M. (1996) J. Biol. Chem. 93, 12969-12973
Cited by
Items 101–198 of 198
β-arrestin 2 stimulates degradation of HIF-1α and modulates tumor progression of glioblastoma
Bae, W., Choi, J., Nam, S., & Jeong, J. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00802-2 · Cited by 37
Self-citationMgcRacGAP Interacts with HIF-1α and Regulates its Transcriptional Activity
Lyberopoulou, A., Venieris, E., Mylonis, I., Chachami, G., Pappas, I., Simos, G., Bonanou, S., & Georgatsou, E. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000110460 · Cited by 36
Jab1 is a target of EGFR signaling in ERα-negative breast cancer
Wang, J., Barnes, R. O., West, N. R., Olson, M., Chu, J. E., & Watson, P. H. (2008) · Breast Cancer Research · doi:10.1186/bcr2105 · Cited by 36
“transcription factors, including c-Jun [26,38], AP-1 [26,38], HIF-1α [39], steroid receptors, and cofactors [40], or the pro-”
BackgroundHong, C. Y., Suh, J. H., Kim, K., Gong, E., Jeon, S. H., Ko, M., Seong, R. H., Kwon, H. B., & Lee, K. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.4841-4852.2005 · Cited by 39
“Interactions between two coactivators or between a nuclear receptor and its coactivator have been reported to increase the stability of one of the participant proteins, resulting in an upregulation of the protein level ( 1 , 19, 31).”
BackgroundSelf-citationHypoxia-inducible factors: Crosstalk between their protein stability and protein degradation
Wei, W., & Yu, X. D. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.08.009 · Cited by 34
Luo, W., Wang, Y., Hanck, T., Stricker, R., & Reiser, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510784200 · Cited by 33
Opposing functions of psoriasin (S100A7) and koebnerisin (S100A15) in epithelial carcinogenesis
Hattinger, E., Zwicker, S., Ruzicka, T., Yuspa, S. H., & Wolf, R. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.04.007 · Cited by 32
JAB1 Determines the Response of Rheumatoid Arthritis Synovial Fibroblasts to Tumor Necrosis Factor-α
Wang, J., Li, C., Liu, Y., Mei, W., Yu, S., Liu, C., Zhang, L., Cao, X., Kimberly, R. P., Grizzle, W. E., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051161 · Cited by 32
Ma, J., Xu, C., Chen, Y., Tao, N., & Qin, Z. (2022) · Cancers · doi:10.3390/cancers14102406 · Cited by 31
Retinoblastoma susceptibility gene product pRB activates hypoxia-inducible factor-1 (HIF-1)
Budde, A., Schneiderhan‐Marra, N., Petersen, G., & Brüne, B. (2005) · Oncogene · doi:10.1038/sj.onc.1208369 · Cited by 31
Sen, J. W., Bergen, H. R., & Heegaard, N. H. H. (2003) · Analytical Chemistry · doi:10.1021/ac026174b · Cited by 32
Hsu, M., Chang, H., & Hung, W. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0077 · Cited by 35
“Up-regulation of HIF-1 by Jab1 in turn stimulates the expression of vascular endothelial growth factor (VEGF), a major HIF-1 target, to enhance tumor angiogenesis (Bae et al. 2002).”
BackgroundXiao, H., Claret, F. X., & Shen, Q. (2019) · Neoplasma · doi:10.4149/neo_2018_181016n772 · Cited by 30
Illescas, O., Pacheco‐Fernández, T., Laclette, J. P., Rodríguez, T., & Rodríguez‐Sosa, M. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155121 · Cited by 30
Jab1 is overexpressed in human breast cancer and is a downstream target for HER-2/neu
Hsu, M., Chai, C., Hou, M., Chang, H., Chen, W., & Hung, W. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.23 · Cited by 30
“Jab1 also binds hypoxia inducible factor-1, prevents its degradation and enhances its transcriptional activity”
BackgroundWerner, T., Shkoda, A., & Haller, D. (2007) · Journal of Proteome Research · doi:10.1021/pr070222x · Cited by 32
Verma, N. K., & Kelleher, D. P. (2014) · European Journal of Immunology · doi:10.1002/eji.201344428 · Cited by 29
Lim, J.-H., Park, J., Kim, S. J., Kim, M.-S., Park, S.-K., Johnson, R. S., & Chun, Y. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.030296 · Cited by 30
“For instance, HIF-1 degradation is enhanced by p53 or OS-9 (Ravi et al., 2000; Baek et al., 2005) and inhibited by hsp90, ARNT, Jab1/CSN5, or HBx (Bae et al., 2002; Isaacs et al., 2004; Katschinski et al., 2004; Moon et al., 2004).”
BackgroundSelf-citationJab1 promotes gastric cancer tumorigenesis via non-ubiquitin proteasomal degradation of p14ARF
Wang, L., Du, W., Xie, M., Liu, M.-R., Huo, F., Yang, J., & Pei, D. (2020) · Gastric Cancer · doi:10.1007/s10120-020-01087-z · Cited by 27
Role of the COP9 Signalosome (CSN) in Cardiovascular Diseases
Milic, J., Tian, Y., & Bernhagen, J. (2019) · Biomolecules · doi:10.3390/biom9060217 · Cited by 29
Wang, H., Dey, D., Carrera, I., Minond, D., Bianchi, E., Xu, S., & Lakshmana, M. K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.476689 · Cited by 28
“Similarly, COPS5 has been shown to directly bind and stabilize another protein, hypoxia-inducing factor 1 (31).”
BackgroundEffect of Chlorella intake on Cadmium metabolism in rats
Shim, J. A., Son, Y. A., Park, J. M., & Kim, M. K. (2009) · Nutrition Research and Practice · doi:10.4162/nrp.2009.3.1.15 · Cited by 26
Self-citationYu, B., Li, M.-H., Wang, W., Wang, Y.-Q., Jiang, Y., Yang, S., Yue, J., Ding, J., & Miao, Z. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0865-4 · Cited by 25
Sumoylation of hypoxia inducible factor-1α and its significance in cancer
Li, J., Xu, Y., Jiao, H., Wang, W., Mei, Z., & Chen, G. (2014) · Science China Life Sciences · doi:10.1007/s11427-014-4685-3 · Cited by 29
Sun, M., Jiang, H., Liu, T., Tan, X., Jiang, Q., Sun, B., Zheng, Y., Wang, G., Wang, Y., Cheng, M., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.08.008 · Cited by 24
Formation and Activity of Template-Assembled Receptor Signaling Complexes
Montefusco, D. J., Shrout, A. L., Besschetnova, T. Y., & Weis, R. M. (2007) · Langmuir · doi:10.1021/la062717r · Cited by 24
Mikus, P., & Zundel, W. (2005) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2005.03.002 · Cited by 25
Heegaard, N. H. H., Jørgensen, T. J. D., Cheng, L., Schou, C., Nissen, M. H., & Trapp, O. (2006) · Analytical Chemistry · doi:10.1021/ac060194m · Cited by 23
Jab1/CSN5 mediates E2F dependent expression of mitotic and apoptotic but not DNA replication targets
Lu, H., Liang, X., Issaenko, O. A., & Hallstrom, T. C. (2011) · Cell Cycle · doi:10.4161/cc.10.19.17618 · Cited by 22
S100A7 (psoriasin) influences immune response genes in human breast cancer
MANDAL, S., CURTIS, L., Pind, M., Murphy, L. C., & Watson, P. H. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.03.020 · Cited by 24
JAB1 enhances HAND2 transcriptional activity by regulating HAND2 DNA binding
Dai, Y., Hao, J., Bonin, C. P., Morikawa, Y., & Cserjesi, P. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20105 · Cited by 22
Kang, G., Hu, M., Ren, H., Wang, J., Cheng, X. M., Li, R., Yuan, B., Balan, Y., Bai, Z., & Huang, H. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0568 · Cited by 22
CSN5 binds to misfolded CFTR and promotes its degradation
Tanguy, G., Drévillon, L., Arous, N., Hasnain, A., Hinzpeter, A., Fritsch, J., Goossens, M., & Fanen, P. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.010 · Cited by 21
Chen, Y., Chen, X., Jiang, Y., Xu, X., Wei, X. E., Gu, X., Liu, C., Zhang, D., & Xu, Z. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1802-z · Cited by 21
HIF1α-Induced by Lysophosphatidic Acid Is Stabilized via Interaction with MIF and CSN5
No, Y. R., Lee, S., Kumar, A., & Yun, C. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137513 · Cited by 22
JAB1 accelerates odontogenic differentiation of dental pulp stem cells
Lian, M., Ye, Z., Shen, Q., Xing, J., Lu, X., Huang, D., Cao, P., Shen, S., Zheng, K., Zhang, J., et al. (2016) · Journal of Molecular Histology · doi:10.1007/s10735-016-9672-5 · Cited by 20
“JAB1 is also the fifth component of the COP9 signalosome (CSN) complex (COPS5), which is involved in various cellular and developmental processes (Bae et al. 2002; Wei and Deng 2003; Martin and Wang 2015).”
BackgroundAn Evolutionary Model for Identifying Genetic Adaptation to High Altitude
MOORE, L. G., Shriver, M. D., Bemis, L., & Vargas, E. (2007) · Springer eBooks · doi:10.1007/978-0-387-34817-9_10 · Cited by 21
Kim, M.-K., Park, H.-J., Kim, Y., Ryu, M. H., Takata, T., Bae, S., & Bae, M. (2013) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2013.10.009 · Cited by 20
Self-citationKugimiya, N., Nishimoto, A., Hosoyama, T., Ueno, K., Takemoto, Y., Harada, E., Enoki, T., & Hamano, K. (2017) · Oncology Letters · doi:10.3892/ol.2017.6994 · Cited by 20
Yang, Y., Liu, L., Sun, J., Wang, S., Yang, Z., Li, H., Huang, N., & Zhao, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.629543 · Cited by 22
Choi, H. Y., Park, N., Na, J. B., Ko, E. S., Park, J., & Yoo, J. C. (2015) · Oncology Reports · doi:10.3892/or.2015.4472 · Cited by 19
Self-citationYeast as a tool to select inhibitors of the cullin deneddylating enzyme Csn5
Cirigliano, A., Stirpe, A., Menta, S., Mori, M., Dell’Edera, D., Pick, E., Negri, R., Botta, B., & Rinaldi, T. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2016.1160901 · Cited by 19
Miyauchi, Y., Kato, M., Tokunaga, F., & Iwaï, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710599200 · Cited by 19
Wicker, C. A., & Izumi, T. (2016) · BMC Genomics · doi:10.1186/s12864-016-3313-y · Cited by 17
COPS5 Triggers Ferroptosis Defense by Stabilizing MK2 in Hepatocellular Carcinoma
Luo, A., Zheng, W., Zhang, Q., Yuan, Y., Li, M., Du, K., Gao, A., Pei, L., Xie, J., Chen, W., et al. (2025) · Advanced Science · doi:10.1002/advs.202416360 · Cited by 21
The Regulatory and Signaling Functions of Zinc Ions in Human Cellular Physiology
Haase, H., & Maret, W. (2010) · CRC Press eBooks · doi:10.1201/9781420059984-11 · Cited by 16
Badowska-Kozakiewicz, A. M., Budzik, M. P., & Przybylski, J. (2016) · Polish Journal of Pathology · doi:10.5114/pjp.2015.57245 · Cited by 20
Roles of Multifunctional COP9 Signalosome Complex in Cell Fate and Implications for Drug Discovery
Li, P., Xie, L., Gu, Y., Li, J., & Xie, J. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25696 · Cited by 14
Parandavar, E., & Yazdanparast, R. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0180-4 · Cited by 14
“In support of the former view, recently it has been shown that under hypoxia, Jab1 (Jun activation domain binding protein 1) competes with p53 for binding to HIF-1α leading to its stabilization and enhanced survival [15].”
CSN5 Promotes Carcinogenesis of Thyroid Carcinoma Cells Through ANGPTL2
Xie, P., Wang, H., Fang, J., Du, D., Tian, Z., Zhen, J., Liu, Y., Ding, Y., Fu, B., Liu, F., et al. (2020) · Endocrinology · doi:10.1210/endocr/bqaa206 · Cited by 13
Kwak, H., Kim, S.-H., Yoo, H. G., Park, S. H., & Lee, C. H. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-005-0035-y · Cited by 15
“In accordance with its deneddylase activity, Jab1 has been implicated in modulating the stability of diverse proteins including p27kipI, HIF-1a and c-Jun (Bae et al. 2002; Claret et al. 1996; Tomoda et al. 1999).”
BackgroundLungu, G. F., Stoica, G., & Wong, P. K. Y. (2008) · Journal of NeuroVirology · doi:10.1080/13550280802093919 · Cited by 13
Downregulation of Cullin 3 Ligase Signaling Pathways Contributes to Hypertension in Preeclampsia
Zhang, Y., Jiang, G., & Zhang, C. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.654254 · Cited by 12
The COP9 Signalosome: Its Possible Role in the Ubiquitin System
Bech‐Otschir, D., Kapelari, B., & Dubiel, W. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch13 · Cited by 12
Peng, X., Wang, Y., Yu, Z., Huang, S., Zhang, S., Zhong, Z., Wang, Y., Liu, S., Wang, K., Nicot, C., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02422-7 · Cited by 11
Sangadala, S., Yoshioka, K., Enyo, Y., Liu, Y., Titus, L., & Boden, S. D. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1823-3 · Cited by 11
Interactions between HIF-1 and Jab1: Balancing Apoptosis and Adaptation
Larsen, M., Høg, A. M., Lund, E. L., & Kristjansen, P. E. G. (2006) · Springer eBooks · doi:10.1007/0-387-26206-7_28 · Cited by 14
Zhang, F., Di, Y., Li, J., Shi, Y., Zhang, L., Wang, C., He, X., Liu, Y., Wan, D., Huo, K., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2006.10.002 · Cited by 10
Altered expression of COP9 signalosome proteins in preeclampsia
Çaylı, S., Demirtürk, F., Ocaklı, S., Aytan, H., Caliskan, A. C., & Cimsir, H. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.633664 · Cited by 10
“Interestingly, Jab1/CSN5 was shown to interact directly with HIF-1a and increased HIF-1a protein levels in hypoxia [9].”
BackgroundCyclic cis-Locked Phospho-Dipeptides Reduce Entry of AβPP into Amyloidogenic Processing Pathway
Fisher, C. L., Resnick, R. J., De, S., Acevedo, L. A., Lu, K. P., Schroeder, F. C., & Nicholson, L. K. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160051 · Cited by 10
Yoo, J. C., Park, N., Choi, H. Y., Park, J., & Yi, G.-S. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.101 · Cited by 10
Self-citationYang, K., Wang, M., Chen, J., Hsu, M., & Hung, W. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22633 · Cited by 8
“Furthermore, Jab1 binds hypoxiainducible factor-1 (HIF-1), prevents its degradation, and enhances its transcriptional activity (Bae et al., 2002).”
BackgroundNemoto, S., Taguchi, K., Matsumoto, T., Kamata, K., & Kobayashi, T. (2011) · Peptides · doi:10.1016/j.peptides.2011.11.018 · Cited by 9
“Moreover, Jab1 increases he protein level of hypoxia-inducible factor (HIF) 1 by enhancing IF1 stability [3].”
BackgroundRegulatory mechanisms and therapeutic potential of JAB1 in neurological development and disorders
Yang, Y., Song, R., Gao, Y., Yu, H., & Wang, S. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00675-w · Cited by 9
Bakema, J. E., Hiemstra, I. H., Bakker, J., de Haij, S., Kok, Y., Adema, G. J., van Egmond, M., Coffer, P. J., van de Winkel, J. G. J., & Leusen, J. H. W. (2010) · European Journal of Immunology · doi:10.1002/eji.200939985 · Cited by 8
Nuclear β-catenin expression is positively regulated by JAB1 in human colorectal cancer cells
Nishimoto, A., Takemoto, Y., Saito, T., Kurazumi, H., Tanaka, T., Harada, E., Shirasawa, B., & Hamano, K. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.09.007 · Cited by 7
Psoriasin (S100A7): a novel mediator of angiogenesis
Mishra, S., Ahirwar, D. K., & Ganju, R. K. (2016) · British Journal of Dermatology · doi:10.1111/bjd.15141 · Cited by 6
Lee, H. J., Chattopadhyay, S., Yoon, W., Bahk, J., Kim, T.-H., Kang, H. S., & Lee, K. (2010) · The Prostate · doi:10.1002/pros.21069 · Cited by 5
Ghorbani, S., & Maleki, M. (2020) · Gene Cell and Tissue · doi:10.5812/gct.99206 · Cited by 5
Pharmacogenetics in lung cancer for the lay doctor
Rosell, R., Vergnenégre, A., Fournel, P., Massutí, B., Camps, C., Isla, D., Sánchez, J. M., Morán, T., Sirera, R., & Tarón, M. (2008) · Targeted Oncology · doi:10.1007/s11523-008-0083-8 · Cited by 5
“More relevant to cancer is the CSN5 interaction with hypoxia-inducible factor 1 alpha (HIF-1α), which leads to HIF-1α protein stabilization and increased angiogenic activity [ 14 ].”
BackgroundSamsa, W. E., Mamidi, M. K., Hausman, B. S., Bashur, L. A., Greenfield, E. M., & Zhou, G. D. (2020) · Bone · doi:10.1016/j.bone.2020.115733 · Cited by 5
“Outside of the CSN complex, Jab1 also plays a versatile role in regulating the localization, stability, and activity of many transcription factors, including p53, HIF-1α, AP-1 family members, and various Smads (8-13).”
BackgroundInfluentialZhong, H., Wang, R., Kelavkar, U. P., Wang, C. Y., & Simons, J. W. (2014) · Cancer Medicine · doi:10.1002/cam4.227 · Cited by 5
Essential and Toxic Metal Transport in the Liver
Ballatori, N., Aremu, D. A., & Madejczyk, M. S. (2010) · CRC Press eBooks · doi:10.1201/9781420059984-c3 · Cited by 5
Biology – cancer metabolic phenotype
Čuperlović‐Culf, M. (2013) · Elsevier eBooks · doi:10.1533/9781908818263.15 · Cited by 4
Osterli, E., Ellenbecker, M., Wang, X., Terzo, M., Jacobson, K., Cuello, D., & Voronina, E. (2024) · Genetics · doi:10.1093/genetics/iyae033 · Cited by 3
Cavalcante, L. D. S., Costa-Silva, T. A., de Souza, T. A., Ienne, S., & Monteiro, G. (2019) · Brazilian Journal of Microbiology · doi:10.1007/s42770-019-00154-7 · Cited by 4
Cao, Z., Yang, S., Zou, J., Jin, Y., Zhang, Y., Chen, T., & Shen, Y. (2026) · APOPTOSIS · doi:10.1007/s10495-025-02246-2 · Cited by 2
Bhardwaj, S., Pandey, S., Ghosh, D. K., Sharma, T., & Jain, B. P. (2026) · World Journal of Experimental Medicine · doi:10.5493/wjem.v16.i1.115478 · Cited by 2
New pathogenic mechanisms in diabetic wound healing
Sunkari, V. G. (2012) · Figshare · Cited by 2
Ins and outs of the IgA receptor, FcαRI
Bakema, J. E. (2007) · Utrecht University Repository (Utrecht University) · Cited by 1
Regulators of angiogenesis in diabetes and tumors
Catrina, S. (2005) · Figshare
The COP9 Signalosome and Its Role in the Ubiquitin System
Bech‐Otschir, D., Kapelari, B., & Dubiel, W. (2008) · Wiley eBooks · doi:10.1002/9783527610754.dd02
Functional analysis of the von Hippel-Lindau tumour suppressor and its role in tumourigenesis
Barry, R. E. (2004) · edoc (University of Basel) · doi:10.5451/unibas-003376459
Mardilovich, K. (2011) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/3w9g-7v51
Gholaman, H. (2012) · DuEPublico (University of Duisburg-Essen)
JAB1/CSN5: A Multifunctional Protein in Cancer
Nishimoto, A. (2014) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000099
“In addition, JAB1/CSN5 is a transcriptional co-activator for c-Jun [1], MYC [10], HIF-1α [11,12] and STAT3 [13].”
BackgroundZinc Homeostatic Proteins and Glia
Silverman, W. F. (2004) · CRC Press eBooks · doi:10.1201/9781420039740.ch22
Molecular Basis for Vascular Endothelial Growth Factor Expression in Tumor
Xie, K., & Yao, J. C. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8341-9_6
“Possible mechanisms include suppression of Sp1 activity by interaction of p53 and promotion of HIF-1 degradation [186–190].”
BackgroundWicker, C. A. (2018) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2018.001
Yu, B., Miao, Z., Jiang, Y. H., Li, M.-H., Yang, N., Li, T., & Ding, J. (2023) · doi:10.1158/0008-5472.c.6499152.v1
Saati, M. O. (2018) · theses.fr (ABES) · doi:10.70675/ebe84908zaf0bz433czb285z52a5ab381634
Μελέτη της αλληλεπίδρασης του μεταγραφικού παράγοντα TFAP2A με δομικές επικράτειες του HIF-1α
Λακάκη, Ε. Κ. (2023) · University of Thessaly Institutional Repository (University of Thessaly) · doi:10.26253/heal.uth.39123
Changes in transcription and phospho-signalling in breast tumour hypoxia and hypoxia-reoxygenation
Aboalmaaly, A. (2024) · Nottingham ePrints (University of Nottingham)
Chen, L., Shen, Y., Zhang, Z., Chen, Q., Hua, X., Zhang, L., Ma, J., Hu, Y., Li, H., Feng, Z., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-10749-0
Metadata
- Authors
- Bae, M.-K., Ahn, M.-Y., Jeong, J.-W., Bae, M.-H., Lee, Y. M., Bae, S.-K., Park, J.-W., Kim, K.-R., & Kim, K.-W.
- Affiliations
- Pusan National University (KR)
- Seoul National University (KR)
- Corresponding author
- Kim, Kyu-Won
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-01
- Volume
- 277
- Issue
- 1
- Pages
- 9-12
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1989183186
- Cited by
- 196
- References
- 25
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 5 · 2017: 7 · 2016: 9 · 2015: 6 · 2014: 6 · 2013: 8 · 2012: 6
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6854 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- Jab1, HIF-1α, HIF-1, protein stability, protein-protein interaction, COP9 signalosome, p53, vascular endothelial growth factor, transcriptional coactivator, hypoxia, AP-1
- MeSH terms
- COP9 Signalosome Complex, Binding, Competitive, Cells, Cultured, DNA-Binding Proteins, Humans, Peptide Hydrolases, Transcription Factors, Transcription, Genetic, Up-Regulation, Tumor Suppressor Protein p53, Intracellular Signaling Peptides and Proteins, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.